Himmelsbach, Vera
Knabe, Mate
Ferstl, Phillip G.
Peiffer, Kai-Henrik
Stratmann, Jan A.
Wichelhaus, Thomas A.
Hogardt, Michael
Kempf, Volkhard A. J.
Zeuzem, Stefan
Waidmann, Oliver
Finkelmeier, Fabian
Ballo, Olivier http://orcid.org/0000-0003-1634-1988
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 3 May 2021
Accepted: 12 July 2021
First Online: 20 July 2021
Declarations
:
: Vera Himmelsbach: nothing to declare. Mate Knabe: nothing to declare. Philip G. Ferstl: consultancies: SNIPR Biome. Kai-Henrik Peiffer: nothing to declare. Jan A. Stratmann: nothing to declare. Thomas Wichelhaus: nothing to declare. Michael Hogardt: nothing to declare. Volkhard Kempf: nothing to declare. Stefan Zeuzem: speaker’s fees: Abbvie, Gilead, Merck/MSD, consultancy: Abbvie, Gilead, Intercept, Janssen. Oliver Waidmann: consultancies: Amgen, Bayer, BMS, Celgene, Eisai, Incyte, Ipsen, Merck Serono, MSD, Novartis, Roche, Servier, Shire; Speaker’s fees: Bayer, BMS, Celgene, Eisai, Ipsen, Novartis, Roche, Shire; Travel support: Abbvie, Bayer, BMS, Gilead, Ipsen, Merck; Grants: Basilea, Incyte, Else Kröner-Fresenius-Stiftung, Medac, Merck Serono, MSD Fabian Finkelmeier: speaker fees from Abbvie, Ipsen, Eisai, and MSD Olivier Ballo: nothing to declare.
: The study was performed in accordance with the Declaration of Helsinki. The study was approved by the institutional review board of the Frankfurt University Hospital.
: Patients provided informed written consent and patient data was provided after approval by the local Ethics Committee.
: Patients provided informed written consent and patient data was provided after approval by the local Ethics Committee.